Recent progress of nanomedicine and targeted drug delivery for cancer treatment / / Huijie Zhang [editor].

• TeilnehmendeR: Zhang, Huijie ,
• Place / Publishing House: Basel : : MDPI,, [2023]; ©2023
• Year of Publication: 2023
• Language: English
• Physical Description: 1 online resource

Currently, cancer is the second leading cause of death worldwide and is the most complex and challenging disease known to humankind. Due to the complex underlying mechanisms of tumorigenesis and tumor metastasis, as well as the intrinsic limitations of conventional cancer therapies, the effective treatment of cancer remains a great challenge. Novel therapeutic strategies with superior anticancer ability urgently need to be discovered. In recent years, nano-drug delivery systems have been extensively investigated and applied as alternatives to conventional cancer treatments. Cancer nanomedicines aim to achieve the targeted delivery of chemotherapeutic drugs to the tumor site, utilizing strategies such as passive targeting, active targeting and stimuli-triggered drug release, while simultaneously decreasing drug accumulation in normal tissues, which together lead to improved therapeutic efficacy and reduced side effects. Currently, several cancer nanomedicines are in regular use, and several others are in various stages of development. This Special Issue will highlight recent progress in the development of novel nanomedicines and targeted drug delivery systems for cancer therapy.

Table of Contents

Ms Farheen, Md Habban Akhter, Havagiray Chitme, Md Sayeed Akhter, Fauzia Tabassum -- and Mariusz Jaremko et al. -- Harnessing Folate-Functionalized Nasal Delivery of Dox-Erlo-Loaded Biopolymeric -- Nanoparticles in Cancer Treatment: Development, Optimization, Characterization, and -- Biodistribution Analysis -- Reprinted from: Pharmaceuticals 2023, 16, 207, doi:10.3390/ph16020207 1 -- Liangju Sheng, Xuanlei Zhu, Miao Sun, Zhe Lan, Yong Yang and Yuanrong Xin et al. -- Tumor Microenvironment-Responsive Magnetic Nanofluid for Enhanced Tumor MRI and -- Tumor multi-treatments -- Reprinted from: Pharmaceuticals 2023, 16, 166, doi:10.3390/ph16020166 31 -- Binghong He and Qiong Yang -- Recent Development of LDL-Based Nanoparticles for Cancer Therapy -- Reprinted from: Pharmaceuticals 2022, 16, 18, doi:10.3390/ph16010018 47 -- Jiabin Xu, Wenqiang Cao, Penglai Wang and Hong Liu -- Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy -- Reprinted from: Pharmaceuticals 2022, 15, 876, doi:10.3390/ph15070876 59 -- Sara Zaher, Mahmoud E. Soliman, Mahmoud Elsabahy and Rania M. Hathout -- Sesamol Loaded Albumin Nanoparticles: A Boosted Protective Property in Animal Models of -- Oxidative Stress -- Reprinted from: Pharmaceuticals 2022, 15, 733, doi:10.3390/ph15060733 87 -- Ibrahim A. Mousa, Taha M. Hammady, Shadeed Gad, Sawsan A. Zaitone, Mohamed -- El-Sherbiny and Ossama M. Sayed -- Formulation and Characterization of Metformin-Loaded Ethosomes for Topical Application to -- Experimentally Induced Skin Cancer in Mice -- Reprinted from: Pharmaceuticals 2022, 15, 657, doi:10.3390/ph15060657 109 -- Mengjie Rui, Min Cai, Yu Zhou, Wen Zhang, Lianglai Gao and Ke Mi et al. -- Identification of Potential RBPJ-Specific Inhibitors for Blocking Notch Signaling in Breast -- Cancer Using a Drug Repurposing Strategy -- Reprinted from: Pharmaceuticals 2022, 15, 556, doi:10.3390/ph15050556 135 -- Hibah M. Aldawsari, Sima Singh, Nabil A. Alhakamy, Rana B. Bakhaidar, Abdulrahman A. -- Halwani and Nagaraja Sreeharsha et al. -- Adenosine Conjugated Docetaxel Nanoparticles-Proof of Concept Studies for Non-Small Cell -- Lung Cancer -- Reprinted from: Pharmaceuticals 2022, 15, 544, doi:10.3390/ph15050544 155 -- Yang Qu, Zhiqi Wang, Miao Sun, Tian Zhao, Xuanlei Zhu and Xiaoli Deng et al. -- A Theranostic Nanocomplex Combining with Magnetic Hyperthermia for Enhanced -- Accumulation and Efficacy of pH-Triggering Polymeric Cisplatin(IV) Prodrugs -- Reprinted from: Pharmaceuticals 2022, 15, 480, doi:10.3390/ph15040480 171 -- Yajing Ren, Chenlin Miao, Liang Tang, Yuxiang Liu, Pinyue Ni and Yan Gong et al. -- Homotypic Cancer Cell Membranes Camouflaged Nanoparticles for Targeting Drug Delivery -- and Enhanced Chemo-Photothermal Therapy of Glioma -- Reprinted from: Pharmaceuticals 2022, 15, 157, doi:10.3390/ph15020157 189.